2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $1,258,916
Activities: HAI Detection and Response Infrastructure; Coordinated Prevention; Data Validation; Hemodialysis Bloodstream Infections (BSI); and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $468,006
Activities: HAI Prevention Infrastructure, Antimicrobial Resistance (AR) Prevention Program, Data Validation, and Hemodialysis
2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
Infection Control Assessment Program: $658,747
Targeted Infection Prevention: $1,655,637
2014 Affordable Care Act (ACA) funding amount: $396,961
Activity: HAI Prevention Infrastructure, Clostridium difficile infection (CDI), Data Validation, and Hemodialysis BSI
2013 Affordable Care Act (ACA) funding amount: $704,151
Activities: HAI Prevention Infrastructure, Prevention of Healthcare-associated Infections Across the Spectrum of Healthcare, and Initial Implementation of the CLABSI Validation Guidance to Ensure the Quality of HAI Data
From 2009-2012 Massachusetts received funding to build HAI infrastructure, conduct surveillance, and engage in prevention activities